NOTV250117P5000
- 0.90
- -0.40-30.77%
Inotiv Newsroom
Insider Purchase: Director at $NOTV (NOTV) Buys 23,529 Shares
Inotiv Raises Net Proceeds of $24 Million From Equity Offering
Inotiv's Strategic Moves and Financial Outlook Support Buy Rating
Inotiv Announces Pricing Of Public Offering Of 6M Common Shares Of Common Stock At A Price Of $4.25/Share
Inotic Shares Are Trading Lower After the Company Announced a Public Offering of Common Shares With a 15% Over-allotment Option.
Express News | Inotic Shares Are Trading Lower After the Company Announced a Public Offering of Common Shares With a 15% Over-allotment Option
Express News | Inotiv, Inc. Launches Proposed Public Offering of Common Shares
Press Release: Inotiv, Inc. Launches Proposed Public Offering of Common Shares
Insider Purchase: Director at $NOTV (NOTV) Buys 10,000 Shares
Inotiv Insider Bought Shares Worth $414,000, According to a Recent SEC Filing
Lake Street Maintains Inotiv(NOTV.US) With Buy Rating, Maintains Target Price $6
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Ascendis Pharma (ASND) and Champions Oncology (CSBR)
Inotiv, Inc. Faces Financial Turmoil: Going Concern Doubts and Debt Pressures
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating, Announces Target Price $10
Lake Street Maintains Inotiv(NOTV.US) With Buy Rating, Raises Target Price to $6
Inotiv | 10-K: FY2024 Annual Report
Inotiv, Inc. (NOTV) Q4 2024 Earnings Call Transcript Summary
Express News | Inotiv Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q4 Financial Results
Inotiv | 8-K: Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
Inotiv 4Q Loss/Shr 73c >NOTV